Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:item
|
| gptkbp:bfsLayer |
3
|
| gptkbp:bfsParent |
gptkb:item
|
| gptkbp:appointed_by |
oral supplement
|
| gptkbp:clinical_trial |
chronic kidney disease
immune system support hypoparathyroidism osteoporosis prevention malabsorption syndromes lower than cholecalciferol |
| gptkbp:composed_of |
gptkb:ergosterol
|
| gptkbp:diet |
600 IU for adults
800 IU for older adults |
| gptkbp:dissolved |
fat-soluble
|
| gptkbp:form |
tablets
capsules liquid drops |
| https://www.w3.org/2000/01/rdf-schema#label |
Ergocalciferol
|
| gptkbp:ingredients |
C28 H44 O
|
| gptkbp:interacts_with |
vitamin D receptors
|
| gptkbp:is_found_in |
gptkb:fungus
|
| gptkbp:is_known_for |
gptkb:Vitamin_D2
|
| gptkbp:is_used_for |
treatment of vitamin D deficiency
|
| gptkbp:marketed_as |
gptkb:Calciferol
D2 Drisdol |
| gptkbp:mass |
396.65 g/mol
|
| gptkbp:metabolism |
gptkb:calcitriol
calcidiol |
| gptkbp:previous_name |
(3 S,5 Z,7 E)-9,10-secocholesta-5,7,10(19)-triene-3,6-diol
|
| gptkbp:produced_by |
UV irradiation of ergosterol
|
| gptkbp:regulates |
calcium levels
phosphate levels |
| gptkbp:research_areas |
mental health
autoimmune diseases cardiovascular health diabetes management cancer prevention |
| gptkbp:safety_features |
generally recognized as safe
|
| gptkbp:side_effect |
nausea
vomiting weakness kidney stones hypercalcemia |
| gptkbp:storage |
liver
|
| gptkbp:symptoms |
osteomalacia
rickets osteoporosis |
| gptkbp:type_of |
1406-16-2
|